C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2002
12/05/2002	WO2002064802A3 Regulatory genes suitable for use in gene expression
12/05/2002	WO2002064757A3 Influenza viruses with enhanced transcriptional and replicational capacities
12/05/2002	WO2002063018A8 Method for the production of plant seed with modified fibre content and modified seed coat
12/05/2002	WO2002062968A3 Micro-tubular materials and cell constructs
12/05/2002	WO2002062957A9 Ter sites and ter binding proteins
12/05/2002	WO2002060924A9 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
12/05/2002	WO2002059150A3 Materials and methods relating to protein aggregation in neurodegenerative disease
12/05/2002	WO2002055675A8 Ancillary composition for the preparation of committed mature dendritic cells
12/05/2002	WO2002053708A8 Method for production of low-cost seeds of hybrid wheat
12/05/2002	WO2002040645A3 Cell constructs which can be obtained from mesenschymal stem cells and cells derivable therefrom and the use thereof
12/05/2002	WO2002038732A3 Human testis specific serine/threonine kinase
12/05/2002	WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof
12/05/2002	WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae
12/05/2002	WO2002020766A3 G-csf analog compositions and methods
12/05/2002	WO2002019893A3 Improved cardiac function through administration of es cells
12/05/2002	WO2002016413A3 Cripto tumour polypeptide
12/05/2002	WO2002006453A3 Regulation of human desc1-like serine protease
12/05/2002	WO2002000715A3 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
12/05/2002	WO2001092491A3 Mammalian protein phosphatases identified by in-silico analysis
12/05/2002	WO2001088085A3 Novel bee venom polypeptides and methods of use thereof
12/05/2002	WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells
12/05/2002	WO2001060397A9 Uses of agonists and antagonists to modulate activity of tnf-related molecules
12/05/2002	WO2001044816A9 Conformational and topological protein regulation
12/05/2002	WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
12/05/2002	WO2001032685A9 Gene expression directed by a super-psa promoter
12/05/2002	WO2001021796A9 Gl50 molecules and uses therefor
12/05/2002	US20020184661 Dna shuffling to produce nucleic acids for mycotoxin detoxification
12/05/2002	US20020184660 Nucleotide sequences coding polypeptide for use in contolling plant seed dehulling
12/05/2002	US20020183844 Microfabricated tissue as a substrate for pigment epithelium transplantation
12/05/2002	US20020183509 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal
12/05/2002	US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
12/05/2002	US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183504 Isolated gene of given sequence, from the family of aspartate-specific cysteine proteases (ASCPs); involved in apoptosis
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer
12/05/2002	US20020183494 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183493 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183269 Novel compounds
12/05/2002	US20020183250 For use in therapy of sleep disorders
12/05/2002	US20020182730 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
12/05/2002	US20020182729 Proliferation of neuronal cells; obtain stem cels, incubate with antagonist of pitutary adenylate cyclase activating polypeptide, moitor proliferation of neuronal cells
12/05/2002	US20020182728 Method for transdifferentiation of non pancreatic stem cells to the pancreatic differentiation pathway
12/05/2002	US20020182727 Activation immune response for use in the treatment of multiple sclerosis, arthritis, autoimmune and infectious diseases; obtain lymphocytes, incubate with inducer, monitor adjustment in disorder
12/05/2002	US20020182725 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/05/2002	US20020182724 Expression vector for use tools in genome analysis and generation of transgenic animals
12/05/2002	US20020182723 Generation of genetically engineered viral vectors; obtain cells, infect with genetically engineered vector, propagate and harvest viral vectors
12/05/2002	US20020182721 Substrate for use in the propagation of cells
12/05/2002	US20020182706 Purification of viral envelope proteins; obtain cell, transfect with genetically engineered virus, lyse cell, recover envelope proteins
12/05/2002	US20020182703 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment
12/05/2002	US20020182698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/05/2002	US20020182691 Nucleotide sequences coding transport protein for use in nervous system disorders
12/05/2002	US20020182686 Generating prevential nucleotide sequences; obtain nucleotide sequences, incubate with primers, expose to polymerase, recover nucleotide sequences
12/05/2002	US20020182683 Vascular endothelial growth factor 2
12/05/2002	US20020182681 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
12/05/2002	US20020182679 Recombinant cell clones having increased stability and methods of making and using the same
12/05/2002	US20020182676 Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia
12/05/2002	US20020182673 Nucleotide sequences coding polypeptide for use in the treatment of degenerative, bone and inflammatory disorders
12/05/2002	US20020182671 Polypeptide for use in the treatment, diagnosis, and prevention of cell proliferative, autoimmune/inflammatory, neurological and gatrointestinal disorders
12/05/2002	US20020182667 Methods of modulating T lymphocyte costimulation
12/05/2002	US20020182664 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components
12/05/2002	US20020182655 Method for identifying ligands for G protein-coupled receptors
12/05/2002	US20020182654 Cell isolation method and uses thereof
12/05/2002	US20020182645 Separation of preferential cells in sample; obtain cells, incubate with label, separate labeled cells, recover cells
12/05/2002	US20020182638 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182592 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/05/2002	US20020182581 Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group
12/05/2002	US20020182261 Forming and preserving a bioremodelable, biopolymer scaffold material; used for hernia repair, prolapse treatment; pelvic floor reconstruction; muscle flap reinforcement; lung tissue support; etc.
12/05/2002	US20020182241 Two-dimensional templates fabricated using high-resolution molding processes are bonded to form three-dimensional scaffold structures with closed lumens.
12/05/2002	US20020182231 Methods of stem cell manipulation for immunotherapy
12/05/2002	US20020182228 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins
12/05/2002	US20020182221 Recombinant papillomavirus vaccine and method for production and treatment
12/05/2002	US20020182218 Therapeutic anti-melanoma compounds
12/05/2002	US20020182211 Binds CD80 and/or CD86; an alanine at position +29 is substituted with tyrosine, leucine, tryptophan, or threonine, and a leucine at position +104 is substituted with a glutamic acid
12/05/2002	US20020182210 Treatment of central nervous system diseases by antibodies against glatiramer acetate
12/05/2002	US20020182209 Leukemic cell-adsorbing column and adsorbent material therefor
12/05/2002	US20020182208 Glycosylated antibody
12/05/2002	US20020182198 Purified MANF polypeptide (mature astrocyte-derived neurotrophic factor) of given sequence
12/05/2002	US20020182197 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby
12/05/2002	US20020182194 Useful as a tumor vaccine
12/05/2002	US20020182193 Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of myopathies like muscular dystrophy, for improving transplantation success
12/05/2002	US20020182192 Administering bone marrow cells to the mammal, such as allogeneic cells or autologous cells engineered to express dystrophin or other gene products
12/05/2002	US20020182189 Compositions and methods for the repair and construction of bone and other tissue
12/05/2002	US20020182188 Making by debulking a suspension of human liver tissue under conditions to remove mature cells, while retaining immature cells having markers for the expression of alpha-fetoprotein, and/or albumin
12/05/2002	US20020182186 Isolated bone marrow composition enriched with physiologically compatible stem cells
12/05/2002	US20020182182 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia
12/05/2002	US20020182178 Use of interleukin - 15
12/05/2002	US20020182177 Methods and compositions for promoting the maturation of monocytes
12/05/2002	US20020182176 Methods and compositions for promoting the maturation of monocytes
12/05/2002	US20020182175 Administration of a reactive oxygen species (ROS) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
12/05/2002	US20020182174 Methods and compositions for promoting the maturation of monocytes
12/05/2002	US20020179537 Separation of platelets from whole blood for use as a healant
12/05/2002	DE10114209A1 Ortsgerichtete Transformation durch Verwendung von Amplifikationsvektoren Site-directed transformation by using amplification vectors
12/05/2002	CA2616769A1 Compositions and methods of increasing stress tolerance in plants
12/05/2002	CA2454557A1 Callus specific plant promoters
12/05/2002	CA2452707A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut
12/05/2002	CA2451838A1 Stem cell differentiation
12/05/2002	CA2449979A1 A method of purification of neural stem cells
12/05/2002	CA2449127A1 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
12/05/2002	CA2449029A1 Modification of plant genomes by inducible site-specific recombination of trans genes

1 ... 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 ... 1827